Lauren Dobson, APRN
Nurse Practitioner · Fremont, NENPI 1306536842
Payments from drug & device makers
Across 71 payments — averaging $16.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$268
- Amgen$140
- Vertex$103
- Pfizer$77
- Otsuka America Pharmaceutical, Inc.$77
- Novo Nordisk$77
- plus $435 from 16 others
What the payments were for
- Food & beverage$1,177100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 16 | $268 |
| Amgen | 9 | $140 |
| Vertex | 4 | $103 |
| Pfizer | 5 | $77 |
| Otsuka America Pharmaceutical, Inc. | 5 | $77 |
| Novo Nordisk | 5 | $77 |
| Boehringer Ingelheim | 4 | $69 |
| Lilly USA, LLC | 4 | $64 |
| AstraZeneca | 4 | $61 |
| Ardelyx, Inc. | 2 | $31 |
| Bayer | 2 | $30 |
| Johnson & Johnson | 1 | $23 |
| Novartis | 1 | $21 |
| Verona Pharma, Inc. | 1 | $20 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $18 |
| Organon | 1 | $17 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $15 |
| Lundbeck LLC | 1 | $15 |
| Esperion Therapeutics, Inc. | 1 | $14 |
| GSK | 1 | $14 |
| Vanda Pharmaceuticals Inc. | 1 | $13 |
| Phathom Pharmaceuticals, Inc. | 1 | $9 |
How this compares
$1,177 in reported general payments places this provider in the 75th percentile of 924 nurse practitioner providers in Nebraska.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Methylprednisolone | 40 | $350 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 34 | $325 |
| Cefdinir | 19 | $298 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 12 | $256 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 16 | $247 |
| Naproxen | 15 | $207 |
| Gabapentin | 12 | $177 |
| Atorvastatin Calcium | 18 | $160 |
| Metoprolol Succinate | 11 | $150 |
| Omeprazole | 19 | $145 |
| Meloxicam | 31 | $140 |
| Doxycycline Hyclate | 16 | $140 |
| Cephalexin | 22 | $137 |
| Triamcinolone Acetonide | 19 | $123 |
| Cyclobenzaprine Hcl | 15 | $113 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Fremont
- Doralia Yanely FloresFremont$10K
- Kristen HammesOmaha$899K
- Amy MuchowiczOmaha$78K
- Winifred SchaedelPalmyra$64K
- Kari CunninghamOmaha$53K
- Laura DonovanOmaha$49K
- Kathleen HealeyOmaha$36K
- Katie RuchOmaha$26K
- Jodi FuehrerGrand Island$25K
- Amanda GuggenmosOmaha$23K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.